BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28393272)

  • 1. Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability.
    Bramswig NC; Lüdecke HJ; Hamdan FF; Altmüller J; Beleggia F; Elcioglu NH; Freyer C; Gerkes EH; Demirkol YK; Knupp KG; Kuechler A; Li Y; Lowenstein DH; Michaud JL; Park K; Stegmann APA; Veenstra-Knol HE; Wieland T; Wollnik B; Engels H; Strom TM; Kleefstra T; Wieczorek D
    Hum Genet; 2017 Jul; 136(7):821-834. PubMed ID: 28393272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures.
    Thierry G; Bénéteau C; Pichon O; Flori E; Isidor B; Popelard F; Delrue MA; Duboscq-Bidot L; Thuresson AC; van Bon BW; Cailley D; Rooryck C; Paubel A; Metay C; Dusser A; Pasquier L; Béri M; Bonnet C; Jaillard S; Dubourg C; Tou B; Quéré MP; Soussi-Zander C; Toutain A; Lacombe D; Arveiler B; de Vries BB; Jonveaux P; David A; Le Caignec C
    Am J Med Genet A; 2012 Jul; 158A(7):1633-40. PubMed ID: 22678713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An episode of acute encephalopathy with biphasic seizures and late reduced diffusion followed by hemiplegia and intractable epilepsy observed in a patient with a novel frameshift mutation in HNRNPU.
    Shimada S; Oguni H; Otani Y; Nishikawa A; Ito S; Eto K; Nakazawa T; Yamamoto-Shimojima K; Takanashi JI; Nagata S; Yamamoto T
    Brain Dev; 2018 Oct; 40(9):813-818. PubMed ID: 29858110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the phenotype of HNRNPU-related neurodevelopmental disorder with emphasis on seizure phenotype and review of literature.
    Taylor J; Spiller M; Ranguin K; Vitobello A; Philippe C; Bruel AL; Cappuccio G; Brunetti-Pierri N; Willems M; Isidor B; Park K; Balasubramanian M
    Am J Med Genet A; 2022 May; 188(5):1497-1514. PubMed ID: 35138025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterization of de novo loss of function variants in HNRNPU.
    Leduc MS; Chao HT; Qu C; Walkiewicz M; Xiao R; Magoulas P; Pan S; Beuten J; He W; Bernstein JA; Schaaf CP; Scaglia F; Eng CM; Yang Y
    Am J Med Genet A; 2017 Oct; 173(10):2680-2689. PubMed ID: 28815871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
    Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
    Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44.
    Ballif BC; Rosenfeld JA; Traylor R; Theisen A; Bader PI; Ladda RL; Sell SL; Steinraths M; Surti U; McGuire M; Williams S; Farrell SA; Filiano J; Schnur RE; Coffey LB; Tervo RC; Stroud T; Marble M; Netzloff M; Hanson K; Aylsworth AS; Bamforth JS; Babu D; Niyazov DM; Ravnan JB; Schultz RA; Lamb AN; Torchia BS; Bejjani BA; Shaffer LG
    Hum Genet; 2012 Jan; 131(1):145-56. PubMed ID: 21800092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative phenotypic and network analysis of 1q44 microdeletion for microcephaly.
    Raun N; Mailo J; Spinelli E; He X; McAvena S; Brand L; O'Sullivan J; Andersen J; Richer L; Tang-Wai R; Bolduc FV
    Am J Med Genet A; 2017 Apr; 173(4):972-977. PubMed ID: 28328126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex.
    Sapir T; Kshirsagar A; Gorelik A; Olender T; Porat Z; Scheffer IE; Goldstein DB; Devinsky O; Reiner O
    Nat Commun; 2022 Jul; 13(1):4209. PubMed ID: 35864088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical findings of 21 previously unreported probands with HNRNPU-related syndrome and comprehensive literature review.
    Durkin A; Albaba S; Fry AE; Morton JE; Douglas A; Beleza A; Williams D; Volker-Touw CML; Lynch SA; Canham N; Clowes V; Straub V; Lachlan K; Gibbon F; El Gamal M; Varghese V; Parker MJ; Newbury-Ecob R; Turnpenny PD; Gardham A; Ghali N; Balasubramanian M
    Am J Med Genet A; 2020 Jul; 182(7):1637-1654. PubMed ID: 32319732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a de novo microdeletion 1q44 in a patient with hypogenesis of the corpus callosum, seizures and microcephaly - A case report.
    Westphal DS; Andres S; Beitzel KI; Makowski C; Meitinger T; Hoefele J
    Gene; 2017 Jun; 616():41-44. PubMed ID: 28336463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and phenotypic dissection of 1q43q44 microdeletion syndrome and neurodevelopmental phenotypes associated with mutations in ZBTB18 and HNRNPU.
    Depienne C; Nava C; Keren B; Heide S; Rastetter A; Passemard S; Chantot-Bastaraud S; Moutard ML; Agrawal PB; VanNoy G; Stoler JM; Amor DJ; Billette de Villemeur T; Doummar D; Alby C; Cormier-Daire V; Garel C; Marzin P; Scheidecker S; de Saint-Martin A; Hirsch E; Korff C; Bottani A; Faivre L; Verloes A; Orzechowski C; Burglen L; Leheup B; Roume J; Andrieux J; Sheth F; Datar C; Parker MJ; Pasquier L; Odent S; Naudion S; Delrue MA; Le Caignec C; Vincent M; Isidor B; Renaldo F; Stewart F; Toutain A; Koehler U; Häckl B; von Stülpnagel C; Kluger G; Møller RS; Pal D; Jonson T; Soller M; Verbeek NE; van Haelst MM; de Kovel C; Koeleman B; Monroe G; van Haaften G; ; Attié-Bitach T; Boutaud L; Héron D; Mignot C
    Hum Genet; 2017 Apr; 136(4):463-479. PubMed ID: 28283832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence that de novo missense and truncating variants in ZBTB18 cause intellectual disability with variable features.
    Cohen JS; Srivastava S; Farwell Hagman KD; Shinde DN; Huether R; Darcy D; Wallerstein R; Houge G; Berland S; Monaghan KG; Poretti A; Wilson AL; Chung WK; Fatemi A
    Clin Genet; 2017 May; 91(5):697-707. PubMed ID: 27598823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A de novo nonsense mutation in ZBTB18 plus a de novo 15q13.3 microdeletion in a 6-year-old female.
    Ehmke N; Karge S; Buchmann J; Korinth D; Horn D; Reis O; Häßler F
    Am J Med Genet A; 2017 May; 173(5):1251-1256. PubMed ID: 28345786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene.
    Caliebe A; Kroes HY; van der Smagt JJ; Martin-Subero JI; Tönnies H; van 't Slot R; Nievelstein RA; Muhle H; Stephani U; Alfke K; Stefanova I; Hellenbroich Y; Gillessen-Kaesbach G; Hochstenbach R; Siebert R; Poot M
    Eur J Med Genet; 2010; 53(4):179-85. PubMed ID: 20382278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo frameshift variants of HNRNPU in patients with early infantile epileptic encephalopathy: Two case reports and literature review.
    Song Z; Zhang Y; Yang C; Yi Z; Li F; Xue J; Yang X; Li B
    Int J Dev Neurosci; 2021 Nov; 81(7):663-668. PubMed ID: 33914968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo 163 kb interstitial 1q44 microdeletion in a boy with thin corpus callosum, psychomotor delay and seizures.
    Selmer KK; Bryne E; Rødningen OK; Fannemel M
    Eur J Med Genet; 2012 Dec; 55(12):715-8. PubMed ID: 22975012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.